Introduction
The Cbl proteins are a family of proteins conserved throughout the animal kingdom (Thien and Langdon, 2001; Nau and Lipkowitz, 2003) . Cbl proteins function as ubiquitin protein ligases (E3s), which mediate the ubiquitination of activated tyrosine kinases, such as the EGFR, and target them for degradation (Thien and Langdon, 2001 ). All of these Cbl proteins have a highly conserved N-terminal region containing a tyrosine kinase-binding domain and a RING finger, which are essential for the targeted E3 activity of Cbl proteins (Levkowitz et al., 1999; Yokouchi et al., 1999) . Only Cbl-b and c-Cbl have a ubiquitin associated (UBA) domain at their C-terminal end (Blake et al., 1991; Keane et al., 1995; Hofmann and Bucher, 1996) .
The UBA domain was recognized originally as a conserved motif occurring in a variety of proteins involved in ubiquitin-mediated processes (Hofmann and Bucher, 1996) . Subsequently, it was shown that the UBA domains of a number of proteins interact with ubiquitin (Bertolaet et al., 2001b; Chen et al., 2001; Wilkinson et al., 2001; Funakoshi et al., 2002; Meyer et al., 2002; Rao and Sastry, 2002; Saito et al., 2002; Ciani et al., 2003; Raasi and Pickart, 2003; Ryu et al., 2003; Chim et al., 2004) . In addition to binding ubiquitin, UBA domains are capable of interacting with ubiquitin-like domains (Ryu et al., 2003) and the ubiquitin-like protein, NEDD8 (Tanaka et al., 2003) . The structures of the UBA domains of HsRad23a (Hofmann and Bucher, 1996; Dieckmann et al., 1998; Withers-Ward et al., 2000; Mueller and Feigon, 2002; Ryu et al., 2003) , p62 (Ciani et al., 2003) , p47 (Yuan et al., 2004) , and Swa2p (Chim et al., 2004) have been described recently. Like the closely related CUE domain, the UBA domain is a tightly packed threehelix bundle with a hydrophobic surface that mediates the interaction with ubiquitin (Hofmann and Bucher, 1996; Dieckmann et al., 1998; Withers-Ward et al., 2000; Mueller and Feigon, 2002; Ciani et al., 2003; Kang et al., 2003; Prag et al., 2003; Ryu et al., 2003; Wang et al., 2003; Chim et al., 2004; Mueller et al., 2004; Yuan et al., 2004) .
In addition, UBA domains have been reported to mediate a number of different protein interactions. For example, the two UBA domains in the DNA repair enzyme, Rad23, mediate its homodimerization and its heterodimerization with the UBA domain of the DNA damage induced protein, Ddi1 (Bertolaet et al., 2001a) . Also, the UBA domains of c-Cbl (UBA c ) and Cbl-b (UBA b ) have been reported to mediate their homodimerization Liu et al., 2003) and may be involved in their heterodimerization (Liu et al., 2003) . As Cbl proteins are E3 ligases, it is of interest to determine whether or not the Cbl UBA domains are able to bind ubiquitin. Here, we show that the UBA b , but not the UBA c , mediates an association with ubiquitinated proteins and that the UBA b binds preferentially to polyubiquitin chains.
Results

Cbl-b interacts with ubiquitinated proteins
While studying the regulation of EGFR degradation by Cbl-b, we observed that Cbl-b coimmunoprecipitates ubiquitinated proteins in cells that have not been stimulated with EGF. To characterize this further we transfected 293T cells with HA epitope tagged ubiquitin and untagged Cbl-b. Immunoprecipitation of Cbl-b resulted in the coprecipitation of high molecular weight (HMW) ubiquitinated proteins ( Figure 1a , top panel). The EGFR was not detected in the HMW ubiquinated proteins that coimmunoprecipitated with Cbl-b from the unstimulated cells, and the association of Cbl-b with HMW ubiquitinated proteins was independent of EGFR cotransfection or EGF stimulation (data not shown). This association could be seen in serum-starved cells (Figure 1 ) as well as in cells that were grown in serum (data not shown). We did not detect larger forms of Cbl-b in the immunoprecipitates (Figure 1a , bottom panel). To confirm that the HMW ubiquitinated proteins were not Cbl-b, we precipitated Cbl-b, denatured the precipitated proteins, allowed them to renature, and then reimmunoprecipitated Cbl-b (Figure 1b ). Cbl-b was precipitated from both the first and second immunoprecipitation ( Figure 1b , lanes 2 and 4), but the HMW ubiquitinated proteins were completely lost upon the second immunoprecipitation (Figure 1b, lane 4) . This indicates that the HMW ubiquitinated proteins are associated with Cbl-b but are not ubiquitinated forms of Cbl-b. In contrast to Cbl-b, we did not observe a constitutive association of c-Cbl with HMW ubiquitinated proteins ( Figure 1c, lane 2) . The association of Cbl-b, but not c-Cbl, with HMW ubiquitinated proteins was also observed with endogenous proteins in Hela and 293T cell lysates (Figure 1d and data not shown). The coprecipitation of HMW ubiquitinated proteins with Cbl-b, but not c-Cbl (Figures 1c  and d ), is not due to different amounts of the two Cbl proteins being precipitated since an antibody (H454), which detects both Cbl proteins, detected similar levels of the proteins when endogenous c-Cbl or Cbl-b were precipitated from a Hela cell lysate (Figure 1d , bottom panel). In order to confirm that the relative amounts of the two Cbl proteins precipitated did not affect our ability to observe an association of HMW ubiquitinated proteins with c-Cbl, we used HA epitope tagged Cbl-b and c-Cbl (Figure 1e) . Mutation of the RING finger of Cbl-b does not affect its association with ubiquitinated proteins ( Figure 1e , lane 1; see also Figure 2a ); therefore we used RING finger mutants of the two Cbl proteins to prevent any autoubiquitination. We also used HA epitope tagged ubiquitin to allow the sensitive detection of ubiquitinated proteins. Using antibodies specific to Cbl-b or c-Cbl we precipitated an excess of c-Cbl We mapped the region of Cbl-b that is required for binding to the HMW ubiquitinated proteins by transfecting 293T cells with various untagged constructs of Cbl-b and HA epitope tagged ubiquitin. The Cbl-b proteins were immunoprecipitated and the precipitates were evaluated for the presence of the HMW ubiquitinated proteins (Figure 2a) . The association of Cbl-b with the HMW ubiquitinated proteins was completely abrogated by deletion of either the entire C-terminal half of the protein or only the UBA b (Figure 2a ; upper panel, lanes 4 and 6). While it was not a consistent finding, the deletion of the tyrosine kinase-binding domain of Cbl-b appeared to enhance the interaction with HMW ubiquitinated proteins (Figure 2a; upper panel, lane 5) . This suggests that the tyrosine kinasebinding domain could negatively regulate the association of Cbl-b with HMW ubiquitinated proteins. The association with the HMW ubiquitinated proteins was not affected by a mutation of the RING finger (C373A), which has been shown to abolish the E3 ligase activity of Cbl-b (Figure 1e and 2a; upper panel, lane 3) (Ettenberg et al., 2001) . Thus, the UBA b is necessary for the association of Cbl-b with HMW ubiquitinated proteins and the E3 ligase activity of Cbl-b is not.
To investigate further the association of the UBA b with HMW ubiquitinated proteins, we generated GST fusion proteins of the UBA domain containing the Cterminus of Cbl-b (GST-UBA b ) or c-Cbl (GST-UBA c ) (see Figure 5a for sequences). These fusion proteins were tested for their ability to pull down ubiquitinated proteins from cell lysates containing HA epitope tagged ubiquitin. GST-UBA b , but not GST-UBA c , precipitated HMW ubiquitinated proteins (Figure 2b ; upper panel). Since the UBA c has been reported to mediate the homodimerization of c-Cbl Liu et al., 2003) , we checked the integrity of the GST-UBA c by testing its ability to pull down full-length c-Cbl from HA epitope tagged c-Cbl transfected cell lysates. The GST-UBA c associates with full-length c-Cbl (Figure 2b ; third panel, lane 4). At long exposures, we were able to observe an association of full-length c-Cbl with GST-UBA b (data not shown). Neither GST-UBA b nor GST-UBA c associated with HA epitope tagged Cbl-b ( Figure 2b , second panel). Thus, the UBA b mediates an interaction between Cbl-b and ubiquitinated proteins, is capable of weakly associating with full-length cCbl, but does not homodimerize. In contrast, the UBA c mediates its homodimerization but neither heterodimerizes with Cbl-b nor associates with ubiquitinated proteins.
The UBA b preferentially binds ubiquitin chains
To assess the direct binding of the UBA b and the UBA c to ubiquitin, GST, GST-UBA b or GST-UBA c were incubated with 1 mg of purified tetraubiquitin (Ub 4 ) chains. GST-UBA b , but not GST-UBA c , associated with Ub 4 chains ( Figure 3a ). As stated in the product literature, Ub 4 chains polymerize upon heating, resulting in oligomers of Ub 4 in both the input and GST-UBA b precipitated lanes ( Figure 3a, lanes 1 and 3) . The ability of GST-UBA b to bind Ub 4 was completely abolished by site-directed mutagenesis of residues G943 and Y944 to A and Q respectively ( Figure 3a , lane 4). These residues are predicted to contribute to the hydrophobic patch essential for ubiquitin binding (Kang et al., 2003; Prag et al., 2003; Ryu et al., 2003; Wang et al., 2003) . The mutation of another residue (L967A) predicted to contribute to this hydrophobic patch had no effect on ubiquitin binding (data not shown). This difference in affinity for Ub 4 was also observed between the UBA b and the UBA c cloned from Mus musculus, Xenopus laevis, and Danio rerio (data not shown). Interestingly, the UBA domain of the single Cbl protein identified in Ciona intestinalis (sea squirt) also bound Ub 4 (data not shown).
To assess the direct binding of the UBA b to monoubiquitin, GST or GST-UBA b were incubated with increasing amounts of purified monoubiquitin. Weak interaction of GST-UBA b with monoubiquitin could be seen when 100 mg of monoubiquitin was used ( Figure 3b , lane 7) and a significant interaction could be The difference in the ability of the UBA b and the UBA c to bind ubiquitin is determined by multiple amino acid differences
Since the UBA b and the UBA c differ in their binding affinity for ubiquitin, we wished to determine which amino acids might be responsible for the differences. Like the UBA b , the UBA domains of Rad23a, UBA(1) and UBA(2), bind ubiquitin (Bertolaet et al., 2001a; Chen et al., 2001; Wilkinson et al., 2001; Rao and Sastry, 2002; Raasi and Pickart, 2003; Ryu et al., 2003) . While they have a similar structure (Hofmann and Bucher, 1996; Dieckmann et al., 1998; Withers-Ward et al., 2000; Mueller and Feigon, 2002; Ryu et al., 2003) , there is very little sequence homology between these UBA domains ( Figure 4a ). For example, the two HsRad23a UBA domains have 49% similarity. In contrast, the UBA b and the UBA c have a much higher degree of homology (85% similarity) to each other, yet differ dramatically in their affinity for ubiquitin. Both Cbl UBA domains are similarly related to the HsRad23a UBA domains; for example, the UBA(1) has 41 and 44% similarity to the UBA b and the UBA c , respectively. This heterogeneity of the UBA sequences makes it impossible to predict ubiquitin binding based on sequence analysis.
Since the interaction between UBA domains and ubiquitin are mediated by a hydrophobic patch on the surface of the UBA domain (Hofmann and Bucher, 1996; Dieckmann et al., 1998; Withers-Ward et al., 2000; Mueller and Feigon, 2002; Ciani et al., 2003; Kang et al., 2003; Prag et al., 2003; Ryu et al., 2003; Wang et al., 2003; Mueller et al., 2004; Yuan et al., 2004) , we compared this area in the Cbl UBA domains. We modeled the UBA b and the UBA c on the solution structure of the UBA(1) of HsRad23 using GeneFold (Jaroszewski et al., 1998) (SYBYL, version 6.8; Tripos, Inc., St Louis, MO, USA) and SWISSMODEL (Schwede et al., 2003) . The UBA(1) of HsRad23a was chosen as the model for the UBA b and UBA c as it was identified as the most similar protein using GeneFold. The hydrophobic surfaces of the UBA b and the UBA c had similar areas, which were much smaller than that of the HsRad23a UBA(1) (Figure 4b ). The hydrophobic patch of both the UBA b and the UBA c is comprised of conserved hydrophobic amino-acid residues that are also found in the hydrophobic patch of the HsRad23a UBA(1). However, other residues that contribute to the HsRad23a UBA(1) hydrophobic patch (e.g. M173 and L199) are polar in both the UBA b and the UBA c . Therefore, it is impossible to draw any conclusions about differences in ubiquitin binding based on the hydrophobic patches of the UBA b and the UBA c . Using these models we predicted a number of residues with different surface exposure in the UBA b and the UBA c , , or GST-UBA c (UBA c ) were used to pull down 1000 mg purified monoubiquitin (Ub). The precipitate was immunoblotted for ubiquitin. 30 ng of purified monoubiquitin was loaded in the input lane. GST fusion proteins were stained with Coomassie Blue which may account for the affinity difference for ubiquitin. However, converting individual residues in the UBA c to their equivalent in the UBA b (S858D; E862A,N863K; Q867E; Q872E; V879E) failed to confer Ub 4 binding on the UBA c (data not shown).
Since we were unable to change the affinity of the UBA c for ubiquitin by any single point mutation, we investigated the contribution of different regions of the Cbl UBA domains in ubiquitin binding. Using PCR we generated GST fusion proteins containing chimeric UBA domains with different combinations of the three predicted helixes of the UBA b and the UBA c (Figure 5a ) and tested their ability to bind free Ub 4 (Figure 5b ). We found that, irrespective of which Cbl UBA domain contributed to the second and third helixes, only those chimeras containing the first helix of the UBA b bound Ub 4 (Figure 5b , lanes 5, 8, and 10; chimera i, iv, and vi). The chimera containing this helix alone with the second two helixes of the UBA c weakly bound Ub 4 compared to the WT UBA b ( Figure 5b , lane 5; chimera i). In contrast, the ability of the chimera containing the first two helixes of the UBA b to bind Ub 4 was indistinguishable from the WT UBA b ( Figure 5b , lane 8; chimera iv), whereas the chimera containing the first and third helixes of the UBA b bound Ub 4 with an intermediate affinity ( Figure 5b , lane 10; chimera vi). Thus, it appears that the first helix of the UBA b is necessary for ubiquitin binding, with the second and third helixes of the UBA b cooperating in the binding of ubiquitin. Since the chimera containing the first two helices of the UBA b bound ubiquitin similarly to the WT UBA b , these two helices together appear to make a major contribution to the ability of the UBA b to bind ubiquitin. Therefore, multiple amino acid differences between the UBA b and the UBA c account for the difference in affinity for ubiquitin.
The UBA b does not affect the downregulation of the EGFR or activated cSrc by Cbl-b
Cbl proteins mediate ubiquitination and degradation of the activated EGFR (Ettenberg et al., 1999b (Ettenberg et al., , 2001 Levkowitz et al., 1999; Waterman et al., 1999; Yokouchi et al., 1999) . We therefore wished to determine if the UBA b affects EGFR downregulation. We compared the ability of WT Cbl-b or Cbl-b with a deletion of its UBA domain (Cbl-b DUBA) to downregulate the EGFR following treatment with EGF (Figure 6a ). Overexpression of both WT Cbl-b and Cbl-b DUBA enhanced downregulation of the EGFR compared to vector transfected cells (Figure 6a ). Quantification of EGFR downregulation revealed that Cbl-b DUBA downregulated the actived EGFR slightly faster than WT Cbl-b, but this difference was not statistically significant ( Figure 6b ). The downregulation of the activated EGFR by Cbl-b results in a shorter duration of downstream signaling pathways, such as the MAP kinase pathway (Ettenberg et al., 1999b) . We therefore measured the effects of the UBA b on the activation of MAP kinase (Figure 6c ). The overexpression of both WT Cbl-b or Cbl-b DUBA similarly decreased the duration and activation of ERK2 compared to EGFR alone (Figure 6c , compare lanes 2, 9, and 14). It is not surprising that the deletion of the UBA b does not significantly affect the ability of Cbl-b to downregulate the activated EGFR. Previous work has shown that cCbl, whose UBA domain does not interact with ubiquitin, and Cbl-3, which does not have a UBA domain, also mediate EGF induced ubiquitination and degradation of the EGFR (Levkowitz et al., 1999; Yokouchi et al., 1999) . Furthermore, deletion of the C-terminal half of either Cbl-b or c-Cbl does not abrogate their ability to mediate ubiquitination or Since the UBA b has no significant effect on the downregulation of the EGFR by Cbl-b we investigated its role in the degradation of another Cbl-b substrate, activated cSrc (Magnifico et al., 2003) . We found that the both WT Cbl-b and Cbl-b DUBA caused a similar decrease in the levels of constitutively active cSrc (Y527F) when coexpressed (Figure 6d (Figure 7b, lane 6) . Thus, the UBA b prevents the degradation of the EGFR after ubiquitination. However, it is not clear as to what role the UBA b plays in the endocytosis and degradation of activated EGFR. As described above, deletion of the UBA b does not significantly affect the downregulation of activated EGFR by Cbl-b (Figure 6 ). The ectopic expression of the UBA b also blocks downregulation of the EGFR mediated by the N-terminal half of Cbl-b (data not shown). These observations suggest that the inhibition of EGFR degradation by the UBA b is due to a nonspecific inhibition of ubiquitin-mediated processes.
To test this we investigated the effects of overexpression of the UBA b or the UBA c on the stability of Mdm2 and Siah-1. These proteins are ubiquitinated and degraded by the proteasome and are difficult to detect when transfected into cells in the absence of proteasome inhibitors (Figures 7c and d) (Lopes et al., 1997; Hu and Fearon, 1999) . Cbl proteins have not been shown to ubiquitinate or degrade either protein. Ectopic expression of the UBA b increases the expression of both Mdm-2 and Siah-1 (Figures 7c and d, lane 4) similar to the degree seen upon proteasome inhibition with MG-132 (Figures 7c and d, lane 3) . The UBA c had no effect on the expression of either protein (Figures 7c and d , lane 5). HMW ubiquitinated proteins were seen in immunoprecipitates of Mdm-2 and Siah-1 from the UBA b transfected or MG-132 treated cells (Figures 7c  and d, panel 2, lanes 3 and 4) . These HMW species probably represent ubiquitinated forms of Mdm-2 and Siah-1, suggesting that, like the EGFR, overexpression of the UBA b is inhibiting degradation but not ubiquination of the proteins. These data suggest that overexpression of the UBA b interferes with ubiquitinmediated processes. This is likely to be a result of the interaction of the UBA b with ubiquitinated proteins. These constructs (i-vi) were bacterially expressed as GST fusion proteins and 5 mg protein was used to pull down 1 mg of purified K48-linked tetraubiquitin (Ub 4 ). The precipitate was immunoblotted (IB) for ubiquitin. 40 ng of purified Ub 4 was loaded in the input lane. GST fusion proteins were stained with Coomassie Blue. When immunoblotting for ubiquitin, the long exposures necessary to detect the low levels of ubiquitin in lane 5 also resulted in the detection of the GST fusion proteins used in the pull downs (*)
The lack of effect of the UBA c is consistent with its inability to interact with ubiquitinated proteins. While this inhibition of ubiquitin-mediated processes does not indicate a specific physiological role for the UBA b , it does provide an in vivo confirmation of the biochemical difference between the UBA b and the UBA c .
Discussion
Here we show that Cbl-b can interact via its UBA domain with ubiquitinated proteins and that the UBA b has a higher affinity for free polyubiquitin than monoubiquitin. In contrast, we were unable to observe any association of the UBA c with ubiquitin. This is the first study to demonstrate that two closely related UBA domains vary in their ability to bind ubiquitin. The difference in affinity of the UBA b and the UBA c for ubiquitin appears to be evolutionarily conserved; these domains cloned from M. musculus, X. laevis, D. rerio, all behaved as those of the human Cbl proteins. C. intestinalis, the most primitive chordate studied, has a single Cbl gene (Nau and Lipkowitz, 2003) . The UBA domain of this Cbl protein binds to Ub 4 chains. Thus, it appears that the difference in affinity for ubiquitin between the UBA c and the UBA b occurred with the divergence of the primordial Cbl into two proteins, Cblb and c-Cbl.
The ability of Cbl-b to bind to ubiquitinated proteins via its UBA domain is similar to a number of other UBA domain containing proteins (Chen and Madura, 2002; Funakoshi et al., 2002; Meyer et al., 2002; Aguilar et al., 2003; Ryu et al., 2003) . Since the UBA b binds free ubiquitin in vitro, it is likely that the association of Cbl-b with ubiquitinated proteins is due to the binding of ubiquitin conjugated to these proteins. While the UBA b , like those of Rad23 (Wilkinson et al., 2001; Rao and Sastry, 2002; Raasi and Pickart, 2003) , Ddi1 (Mud1) (Bertolaet et al., 2001b; Wilkinson et al., 2001) , and p62 (Ciani et al., 2003) binds free K48 linked Ub 4 chains with much higher affinity than monoubiquitin in vitro, it may be that the UBA b physiologically interacts with mono-, not polyubiquitinated proteins. The Ubiquitin Interacting Motif and the UBA-like CUE domain both bind polyubiquitin chains in vitro with much higher affinity than monoubiquitin, yet many proteins containing these domains only appear to interact with monoubiquitinated proteins in vivo (reviewed in Schnell and Hicke, 2003) . Although the HMW of the ubiquitinated proteins that associate with Cbl-b suggests that they are polyubiquitinated, further studies will be necessary to determine their ubiquitination state.
In contrast to Cbl-b, we did not detect an association of c-Cbl with ubiquitinated proteins. Furthermore, a GST fusion of the UBA containing C-terminus of c-Cbl did not bind to either ubiquitinated proteins or purified ubiquitin, suggesting that the UBA c does not mediate an association with ubiquitinated proteins. However, Kleijnen et al. (2003) have recently reported that a GST-fusion of the UBA c binds ubiquitinated proteins in a Hela cell lysate. The reason for this different result is not clear. However, the GST pulldowns in the present study were conducted with approximately 10 times less While it may be that we did not detect low-affinity binding of the UBA c to ubiquitin in our assay, the difference in ubiquitinated protein binding could also be explained by the differences in the GST fusion proteins used in the two studies. The GST-UBA c construct used in the present study contained 17 c-Cbl amino acids upstream of the UBA c , whereas the construct used by Kleijnen et al contains 10 amino acids. While these upstream amino acids may regulate the binding of the UBA c to ubiquitin, swapping the UBA helixes between the UBA b and the UBA c suggests that the amino-acid sequence of the UBA c itself accounts for the inability to observe ubiquitin binding in the present study ( Figure 5) . Nevertheless, the inability of our GST-UBA c construct to bind ubiquitin reflects the failure to observe an association between full-length c-Cbl and ubiquitinated proteins (Figure 1c-e) , suggesting that the UBA c in the context of the entire c-Cbl protein does not bind ubiquitin. Thus, we have demonstrated a clear difference in the affinity of the UBA b and the UBA c for ubiquitin. Although the UBA c does not bind ubiquitin, it may bind ubiquitin-like domains or ubiquitin-like proteins such as NEDD8.
The ability of the isolated Cbl UBA domains to associate with full-length c-Cbl is in agreement with previous studies describing the involvement of the UBA domains of these proteins in their homo-and heterodimerization Liu et al., 2003) . In contrast, we were unable to demonstrate an association between the UBA c or the UBA b and full-length Cbl-b. The inability to observe an association of fulllength Cbl-b with either one suggests that regions other than the UBA domain are involved in the homodimerization of Cbl-b and the heterodimerization of c-Cbl and Cbl-b. Since the isolated UBA b does not appear to dimerize in the present study, it is possible that the dimerization of the isolated UBA c prevents binding to ubiquitin; certainly, it has been shown that the dimerization of Rad23 prevents ubiquitin binding (Bertolaet et al., 2001b) . However, this is unlikely given that the chimera of the first and third helix of the UBA b and the second helix of UBA c is able to bind both Ub 4 chains and full-length c-Cbl (Figure 5b , lane 8 and data not shown). The in vitro difference in the affinity for ubiquitin of the Cbl UBA domains was confirmed in vivo by their overexpression in 293T cells. The UBA b , but not the UBA c , inhibited a number of ubiquitinmediated processes, such as the degradation of ubiquitinated proteins (Figure 7) , consistent with their in vitro affinity for ubiquitin. The inhibition of ubiquitinmediated processes by the overexpression of the UBA b provides a useful tool whereby ubiquitin-mediated processes, such as receptor downregulation, can be experimentally manipulated.
The UBA and CUE domains have both been demonstrated to interact with ubiquitin via a hydrophobic patch (Hofmann and Bucher, 1996; Dieckmann et al., 1998; Withers-Ward et al., 2000; Mueller and Feigon, 2002; Ciani et al., 2003; Kang et al., 2003; Prag et al., 2003; Ryu et al., 2003; Wang et al., 2003; Mueller et al., 2004; Yuan et al., 2004) . Molecular modeling of the UBA b and the UBA c suggests that the hydrophobic surfaces of these domains are similar to each other ( Figure 4b ). Thus, differences in affinity for ubiquitin are likely to be due to other residues affecting the structure of the UBA domain. Swapping of the helixes between the UBA b and the UBA c revealed that differences between the first helix of the UBA c and the UBA b are critical for the difference in affinity for ubiquitin. Sequence differences in the second and third helixes of the Cbl UBA domains also appear to contribute to the relative affinity of the two domains for ubiquitin, with the second helix making a greater contribution than the third helix of the UBA b to ubiquitin binding ( Figure 5 ). The relative contribution of the three helixes of the UBA b to ubiquitin binding is confirmed by mutations in the predicted hydrophobic patch of the UBA b . Mutation of two residues in the loop linking helixes 1 and 2 (G943A and Y944Q; Figure 3a ) abolished ubiquitin binding, as has been demonstrated for the equivalent resides in other UBA domains (Wilkinson et al., 2001; Saito et al., 2002) . In contrast, mutation of L967A, which is also predicted to contribute to the hydrophobic patch, failed to affect ubiquitin binding (data not shown), suggesting that the first two helixes of the UBA b make a greater contribution to ubiquitin binding than the third helix. Interestingly, this L to A mutation abolishes the interaction of the UBA domain of Ddi1 with ubiquitin (Bertolaet et al., 2001b) , implying a difference in the interaction with ubiquitin. This suggests that these domains vary in their interaction with ubiquitin, as is the case for the two HsRad23a UBA domains (Mueller et al., 2004) , the p47 UBA domain (Yuan et al., 2004) and the related CUE domain (Kang et al., 2003; Shih et al., 2003) . The determination of the structure of the UBA b and the UBA c should allow for the differences in their affinity for ubiquitin to be elucidated.
Since Cbl-b is able to act as an E3 ligase to mediate growth factor receptor endocytosis and downregulation (Ettenberg et al., 1999b; Levkowitz et al., 1999) , it is tempting to speculate that the UBA b couples Cbl-b to the endocytotic pathway. Many proteins in this pathway bind to monoubiquitinated endocytotic cargo via ubiquitin-interacting domains (reviewed in Bonifacino and Traub, 2003; Schnell and Hicke, 2003) . While overexpression of the UBA b blocked degradation of the EGFR (Figure 7a and b) , deletion of the UBA b does not significantly alter the ability of Cbl-b to downregulate activated EGFR (Figure 6 ) (Ettenberg et al., 2001) . Although studying the end point of EGFR internalization by Cbl-b (i.e. EGFR degradation) does not rule out a subtle effect of the UBA b on endocytosis, it suggests that the UBA b is not involved in endocytosis -at least not of the EGFR. Truncated forms of c-Cbl without a UBA domain are also capable of downregulating tyrosine kinases, such as the EGFR (Levkowitz et al., 1998; Joazeiro et al., 1999; Lill et al., 2000) . Nevertheless, there is some evidence that deletion of the UBA c , and presumably prevention of the homodimerization of c-Cbl, attenuates its association with activated tyrosine kinases. Deletion of the UBA c reduces the tyrosine phosphorylation of c-Cbl in response to EGFR activation and reduces its association with the activated EGFR . Similarly, the UBA c is also necessary for the insulin-stimulated association of c-Cbl with the adaptor protein, APS, and the tyrosine phosphorylation of c-Cbl. Overexpression of c-Cbl with a deleted UBA domain acts as a dominant-negative, inhibiting the insulin-stimulated translocation of the glucose transporter protein 4 (Liu et al., 2003) . Interestingly, a truncated form of c-Cbl missing its UBA domain is present in the cutaneous T-cell lymphoma line, HUT78 (Blake and Langdon, 1992) . While this form of c-Cbl does not transform 3T3 fibroblasts (Blake et al., 1993) , deletion of the UBA c may play a role in oncogenesis, presumably by the reduced recruitment of c-Cbl to activated tyrosine kinases. Additional work will be necessary to determine this. Splice variants of Cbl-b without a UBA domain have been identified (Keane et al., 1995) , but the physiological role of these is unclear.
Like Cbl-b, it is not clear how the ability to bind ubiquitin affects the function of a number of UBA domain containing proteins. For example, mutations in the UBA domain of p62, which are associated with Pagets disease, do not affect ubiquitin binding (Ciani et al., 2003) . In contrast, the UBA domains of proteins in the UbL-UBA family, such as Rad23 and Ddi1, have been demonstrated to play a role in the proteolytic pathway, although it is not clear whether these proteins act to promote or inhibit proteolysis (reviewed in Madura, 2002) . One mechanism by which the UBA domains of Rad23 may affect proteolysis is by the inhibition of the multiubiquitination of proteins (Chen et al., 2001; Raasi and Pickart, 2003) ; a similar prevention of protein multiubiquitination by the UBA b may modulate its E3 activity. The ability of the UBA b to bind ubiquitin could also play a role in the targeting of the E3 activity of Cbl-b, as has been suggested for the p97 (Cdc48p) adaptor protein p47 -the UBA domain of p47 is necessary for the AAA ATPase p97 to reassemble mitotic Golgi (Meyer et al., 2002) . The UIM and CUE domains of a number of proteins also have been shown to mediate their monoubiquitination (reviewed in Schnell and Hicke, 2003) . For example, the yeast E3 ligase, Rsp5, binds the CUE domain of Vsp9 and ubiquitinates it Shih et al., 2003) . Interestingly, the UBA domain of the yeast protein, Gts1p, is involved in its ubiquitination and degradation (Saito et al., 2002) , suggesting that, like other ubiquitin binding domains, the UBA domain may mediate intermolecular ubiquitination. Further studies will be necessary to determine if this is the case for the UBA b . The identification of the ubiquitinated proteins that constitutively associate with Cbl-b will allow an insight into the function of the UBA b .
The biochemical differences between the UBA b and the UBA c suggest that there will be clear functional differences between the Cbl proteins mediated by these domains. The phenotypic differences between c-Cbl and Cbl-b null mice indicate that this is indeed the case. For example, the spontaneous autoimmunity observed in Cbl-b null mice appears to be due to the uncoupling of the CD28 costimulatory pathway from the activation of mature T cells (Bachmaier et al., 2000; Chiang et al., 2000; Zhang et al., 2002) , whereas c-Cbl null mice have enhanced positive selection of CD4 þ thymocytes (Naramura et al., 1998) . However, it is not clear what physiological role(s) the UBA domains of the Cbl proteins have and whether they play a role in these pathways. Further studies will be needed to identify the signaling pathways affected by the UBA domains of the Cbl proteins.
